Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Angiotensin converting enzymes inhibitors are now regarded as the cornerstone of congestive heart failure therapy owing to established reduction in mortality and the symptomatic amelioration following their use. Although the response to converting enzyme inhibitor therapy may be influenced by race,...
| Format: | Article |
|---|---|
| Published: |
1996
|
| Tags: |
No Tags, Be the first to tag this record!
|